April 1, 2020
Belgium-based FibriCheck, the maker of apps that monitor a user's heart rhythm, announced yesterday that it has developed a new version of its smartwatch offering that is capable of scanning for atrial fibrillation while the wearer is asleep.
FibriCheck said in a release that the updated app is currently nearing the end of user testing, and that it will be available for smartwatch manufacturers...
March 3, 2020
Fitbit and Belgium-based FibriCheck have extended their partnership to bring the latter’s atrial fibrillation detection app to four new countries in the EU: France, Germany, Italy and Spain. It was previously made available to Fitbit smartwatch users in the UK, Ireland, the Netherlands and Belgium back in September 2019.
“For more than a decade, Fitbit has helped millions of people around the...
September 24, 2019
Fitbit and Belgium-based FibriCheck announced today that device owners living in certain UK countries now have access to a smartwatch app that uses photoplethysmography (PPG) to detect heart rhythm irregularities such as atrial fibrillation.
Available in Belgium, the UK, the Netherlands and Ireland, the CE-marked tool is similar to FibriCheck’s smartphone app in that it uses light and sensors to...
October 10, 2018
Last week FibriCheck announced that it received FDA 510(k) clearance for its app, which uses a smartphone’s camera and artificial intelligence to monitor for heart rhythm disorders. With this, the Belgian company expects to bring its product to the US market sometime in 2019.
To identify atrial fibrillation, FibriCheck monitors the user's heart rhythm via photoplethysmography. From there, an...